NDC 51672-4045-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4045
- Requested NDC
- 51672-4045-01
- Package NDCs from labels
- 51672-4045-1, 51672-4045-3, 51672-4045-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4045-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4045-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4045 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4045-1 | EA - Each | 51672-4045 | 65069710-3c5b-4339-ba87-09ceb26cf720 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | American Health Packaging | 13ed002f-c5bb-401c-891a-70b70cbd8fb6 | 2025-06-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| INFANT 4.2% SODIUM BICARBONATE | INFANT 4.2% SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | 78c25911-0042-664e-e053-2a91aa0a57a1 | 2025-06-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| Benazepril Hydrochloride and Hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Sandoz Inc | c9bdfbb4-87b6-4de4-bc1d-5025d3ef591f | 2025-06-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | 33f3b980-b339-4dbf-99bd-05588c2a298c | 2025-06-13 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 352061ee-942d-6cba-e063-6294a90a9eea | 2025-06-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f7415f1d-98c7-454f-bb1a-f59e95652c88 | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Aquavit | AQUAVIT | Uriel Pharmacy Inc. | c1c0887a-c388-c737-e053-2a95a90a076c | 2025-06-06 | Warnings | 1K09F3G675 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 794d4a5a-de31-4878-95d5-23552dd2171e | 2025-06-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 744c1785-42b2-46a5-b0f4-2887a9ec2051 | 2025-06-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | e9ecbadb-c548-6fe5-e053-2a95a90a7577 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | f1df0d1e-d418-4f6e-a04a-77b5d4000e2b | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | c59c4230-7cea-4259-9f2f-6a568716fedf | 2025-06-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | 8MDF5V39QO |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8d3e9c30-8dcf-491a-a515-6890b391398e | 2025-05-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Sterile Water | WATER | Henry Schein, Inc. | 88403fcf-a276-42c0-88b6-bd84a720b564 | 2025-05-29 | Warnings, Adverse reactions | 059QF0KO0R |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | d55b2f01-5cd1-40bb-8d36-34b5b9081ddc | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 46addda8-f798-4207-b8fb-ea75c5903a36 | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| AHHH Bite Relief | SODIUM BICARBONATE | 78271 | 25a1e070-9228-4ec9-e063-6294a90ad78d | 2025-05-27 | Warnings | 8MDF5V39QO |
| Bestmade Natural Products Sodium Bicarbonate (Nat Bicarb) | SODIUM BICARBONATE | Bestmade Natural Products | 2fad1d83-3c64-f1b3-e063-6294a90aa3e5 | 2025-05-26 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.